Skip to main content
. 2011 Dec 15;2(1):48–54.

Table 3.

Impact of 111In-capromab pendetide SPECT/CT readings on the clinical management of prostate cancer. The impact was defined as the occurrence of the 111In-capromab pendetide interpretations that resulted in additional correlative studies such as extra imaging procedures and biopsies.

Impact yes no percentage
SPECT/(low-mA)CT 2 15 11.8 %
SPECT/MDCT 8 13 38.1 %